AVXL

Anavex Life Sciences Stock Analysis

AI Rating

Low
  • Quality3/10
  • Growth 4/10
  • Momentum 2/10
Anavex Life Sciences sales and earnings growth
AVXL Growth
Neutral
  • Revenue Y/Y 0.00%
  • EPS Y/Y 16.36%
  • FCF Y/Y 4.32%
Anavex Life Sciences gross and profit margin trends
AVXL Profitability
Low
  • Gross margin 0.00%
  • EPS margin 0.00%
  • ROIC 408.90%
Anavex Life Sciences net debt vs free cash flow
AVXL Risk
Great
  • Debt / Equity 0.0
  • Debt / FCF 0.0
  • Interest coverage NA

Anavex Life Sciences stock volatility is in-line with the overall market. We give it a Great risk rating.

More Biotechnology stocks ↗